PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 214 filers reported holding PDL BIOPHARMA INC in Q1 2015. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $138,000 | -21.6% | 27,371 | 0.0% | 0.11% | -15.7% |
| Q2 2015 | $176,000 | -40.1% | 27,371 | -34.6% | 0.13% | -40.1% |
| Q1 2015 | $294,000 | -15.0% | 41,821 | -6.7% | 0.21% | -18.8% |
| Q4 2014 | $346,000 | -2.3% | 44,821 | -5.4% | 0.26% | -7.1% |
| Q3 2014 | $354,000 | -21.2% | 47,391 | +2.2% | 0.28% | -21.9% |
| Q2 2014 | $449,000 | +129.1% | 46,361 | +96.8% | 0.36% | +108.1% |
| Q1 2014 | $196,000 | +1.0% | 23,556 | +2.5% | 0.17% | 0.0% |
| Q4 2013 | $194,000 | – | 22,971 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |